ArticleBioMed research international2026
Deep Learning Approaches for Multiple Sclerosis Detection in MRI Images.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep Learning Approaches for Multiple Sclerosis Detection in MRI Images.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) is a chronic neurological disorder commonly diagnosed through magnetic resonance imaging (MRI). Manual interpretation of MRI scans is time-consuming and prone to observer variability. This study explores the use of deep learning (DL) models to automate MS lesion detection in MRI images. Four convolutional neural network (CNN) architectures-AlexNet, VGG16 pretrained on ImageNet, ResNet-10, and DenseNet-121-were utilized with slight modifications to optimize their performance for medical imaging tasks. The dataset, comprising 2831 FLAIR and T2 MRI slices from 60 patients, was extensively preprocessed, including normalization, resizing, and augmentation. The models were trained using the Adam optimizer and binary cross-entropy loss function and evaluated on metrics such as accuracy, precision, recall, and F1-score. VGG16 demonstrated the highest performance, with an area under the curve (AUC) of 0.94, followed by DenseNet-121 with an AUC of 0.91, and both AlexNet-C and ResNet-10 with an AUC of 0.90. VGG16 also achieved the highest precision (0.81) and recall (0.93), resulting in the top F1-score (0.86). ResNet-10, however, showed the best balance between efficiency and performance, making it highly suitable for deployment in resource-constrained environments, while DenseNet-121 and AlexNet-C were resource-inefficient given their comparable performance to ResNet-10. These findings underscore the potential of DL models to automate MS lesion detection, offering reliable, efficient, and scalable solutions for clinical diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.